NBCL - Novel Biomarkers Catalyst Lab

NBCL was founded in 2012 and moved to our current location at Kerkenbos in Nijmegen, the Netherlands early 2013. We are dedicated to helping our customers realize the commercial potential of their novel diagnostic products.  NBCL has an experienced research and development team, and each team member is accustomed to establishing close working relationships with our partners on a day-to-day basis. Flexibility is a core value at NBCL, and this has enabled us to provide our partners with quick market introductions of new and innovative products.

The management team of NBCL:

Chris Rosmalen (Chief Executive Officer)NBCL Chris Rosmalen has worked in the IVD industry since 1999 in both commercial and technical roles.  Chris has collaborated with numerous global diagnostics organizations, as well as smaller innovative enterprises and start-up companies.

Michael Jansen, PhD (Chief Technical Officer)NBCL Michael Jansen has extensive experience as technical project leader in IVD product development for both large international organizations and start-up companies since 2002. Michael is a biotechnology expert with a PhD from the University of Groningen. 
Luc Rosmalen (Chief Operating Officer)NBCL Luc Rosmalen has worked in the IVD industry since 1997 in finance and business, working together with many international organizations. 
This website uses cookies to measure the visit, we store NO personal information.